Abstract-Preeclampsia is associated with widespread maternal vascular dysfunction, which is thought to be mediated by circulating factor(s). The aim of the study was to characterize vascular function in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia and to investigate the role of plasma factors in mediating any observed changes in vascular reactivity. Mean arterial blood pressure and vascular function were measured in RUPP and control rats. Mesenteric vessels from both virgin and pregnant rats were exposed for 1 hour or overnight to plasma from both RUPP and control rats and their vascular function assessed. RUPP rats were characterized by severe hypertension, restricted fetal growth, and reduced placental weight (PϽ0.001 The residual relaxant response in RUPP plasma-treated vessels was not further attenuated after treatment with N -nitro-L-arginine methyl ester (acetylcholine: 57Ϯ7 versus 63Ϯ7%, ns; bradykinin: 37Ϯ5 versus 35Ϯ5%, ns). The RUPP rat model is characterized by an impaired response to vasodilators which may be attributable to one or more circulating factors. This plasma-mediated endothelial dysfunction appears to be a pregnancy-dependent effect. Furthermore, nitric oxide-mediated vasorelaxation appears to be absent in RUPP plasma-treated vessels. Key Words: preeclampsia Ⅲ reduced uterine perfusion pressure Ⅲ endothelium Ⅲ hypertension Ⅲ plasma Ⅲ nitric oxide P reeclampsia (PE) is a multisystemic disorder of pregnancy which affects more than 8 million pregnancies worldwide annually. 1 The underlying etiology is incompletely understood, but current thinking suggests the development of a relatively hypoperfused placenta stimulates the maternal response, including alterations in the maternal vascular endothelium. 2 Impaired endothelium-dependent responses have been reported in systemic vessels isolated from women with PE. 3,4 Moreover, numerous studies have demonstrated disparities in terms of the relative contributions of nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI 2 ) to vasodilatation in both physiological 5-8 and pathophysiological pregnancies. 3,6,9 In addition, the vascular dysfunction associated with PE has been shown to be induced by one or more circulating mediators as impaired relaxation was detected in resistance vessels exposed to plasma from women with PE. 10,11 Several animal models of pregnancy-induced hypertension (PIH) exist including the reduced uterine perfusion pressure (RUPP) rat, which involves the chronic reduction of uteroplacental perfusion resulting in a pregnancy-dependent hypertensive state. 12,13 Although a number of gene knockout models of PIH (Comt Ϫ/Ϫ 14 and BPH/5 15 mice) have emerged, those using chronic reduction of uteroplacental perfusion are still largely considered to be more sympathetic to the human condition as they are characterized by hypertension, reduced glomerular filtration rate, proteinuria, intrauterine growth restriction, and endothelial dysfunction. 13 Although PE is a complex con...